Cisatracurium reduces pain on injection of Propofol

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0000451

Enrollment

200

Registered

2012-05-30

Start date

2010-10-20

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : In Group 1, patients were pre-treated with IV normal saline, in Group 2, patients were pre-treated with preservative-free lidocaine IV 0.5 mg kg-1, in Group 3, patients were pre-treated with ci

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - The American Society of Anesthesiologists(ASA)Physical Status classification; I or II - No significant laboratory abnormalities

Exclusion criteria

Exclusion criteria: -American Society of Anesthesiologists’ Physical Status Classification(ASA) 3~5 -Chronic patients receiving benzodiazepines or opioids / other analgesics for control of acute pain will be excluded. -Patients with known allergies to any of the study drugs, or to soybean oil or egg lecithin are excluded. -Women with a positive pregnancy test reported from pre-surgical testing or their physician's office. -Patients with psychiatric disorders are excluded.

Design outcomes

Primary

Measure	Time frame
Intensity of pain on injection that is caused by propofol	—

Secondary

Measure	Time frame
Adverse effects (airway obstruction, diplopia, etc.)	—

Countries

Korea, Republic of

Contacts

Public ContactYun-Hee Kim

Korea University Ansan Hospital

Outcome results